BX Swiss TOP 30 CHF
1.547,28
PKT
-17,86
PKT
-1,14
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.09.26 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 21.09.26 | Nestlé Hold | Deutsche Bank AG | |
| 21.09.26 | UBS Outperform | RBC Capital Markets | |
| 18.09.26 | Givaudan Hold | Jefferies & Company Inc. | |
| 18.09.26 | Swiss Re Kaufen | DZ BANK | |
| 18.09.26 | Nestlé Buy | Jefferies & Company Inc. | |
| 18.09.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.09.26 | Novartis Hold | Deutsche Bank AG | |
| 18.09.26 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.26 | Richemont Buy | UBS AG | |
| 17.09.26 | Richemont Outperform | Bernstein Research | |
| 17.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 17.09.26 | Novartis Neutral | UBS AG | |
| 16.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 15.09.26 | Novartis Hold | Deutsche Bank AG | |
| 14.09.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 14.09.26 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 11.09.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.26 | Richemont Outperform | RBC Capital Markets | |
| 09.09.26 | Novartis Hold | Deutsche Bank AG | |
| 09.09.26 | Novartis Sector Perform | RBC Capital Markets | |
| 08.09.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Novartis Sell | Deutsche Bank AG | |
| 08.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 08.09.26 | Novartis Equal Weight | Barclays Capital | |
| 08.09.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 07.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.09.26 | Swiss Re Underperform | RBC Capital Markets | |
| 04.09.26 | Swiss Re Underweight | Barclays Capital | |
| 04.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 03.09.26 | Givaudan Buy | Deutsche Bank AG | |
| 02.09.26 | Novartis Buy | Deutsche Bank AG | |
| 02.09.26 | Nestlé Neutral | UBS AG | |
| 02.09.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 01.09.26 | Novartis Neutral | UBS AG | |
| 01.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 01.09.26 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | Givaudan Hold | Jefferies & Company Inc. | |
| 01.09.26 | UBS Outperform | RBC Capital Markets |